07:00 , May 10, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Autoimmune disease Dedicator of cytokinesis 2 (DOCK2) In vitro and mouse studies identified a small molecule DOCK2 inhibitor that could help treat autoimmune disease....